INMUNE BIO INC. Amortization of Debt Discount (Premium)
INMUNE BIO INC. (INMB) reported Amortization of Debt Discount (Premium) of $79.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2025-08-07
- INMUNE BIO INC. amortization of debt discount (premium) for the quarter ending 2024-12-31 was $6.00K, a 86.67% decline year-over-year.
- INMUNE BIO INC. amortization of debt discount (premium) for the quarter ending 2024-09-30 was $15.00K, a 72.22% decline year-over-year.
- INMUNE BIO INC. amortization of debt discount (premium) for the quarter ending 2024-06-30 was $24.00K, a 58.62% decline year-over-year.
- INMUNE BIO INC. amortization of debt discount (premium) for the quarter ending 2024-03-31 was $34.00K, a 49.25% decline year-over-year.
- INMUNE BIO INC. amortization of debt discount (premium) for fiscal 2024 was $79.00K, a 64.73% decline from fiscal 2023.
- INMUNE BIO INC. amortization of debt discount (premium) for fiscal 2023 was $224.00K, a 6.28% decline from fiscal 2022.
- INMUNE BIO INC. amortization of debt discount (premium) for fiscal 2022 was $239.00K, a 89.68% increase from fiscal 2021.
- INMUNE BIO INC. amortization of debt discount (premium) for fiscal 2021 was $126.00K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2024-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $21.00K derived: sum of 2 quarters · filed 2025-03-27 | $45.00K derived: sum of 3 quarters · filed 2025-08-07 | $79.00K 10-K · filed 2025-03-27 |
| 2024-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $39.00K derived: sum of 2 quarters · filed 2025-08-07 | $73.00K 10-Q · filed 2024-10-31 | $118.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $58.00K 10-Q · filed 2025-08-07 | $103.00K derived: sum of 3 quarters · filed 2025-08-07 | $157.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $34.00K 10-Q · filed 2025-05-08 | $79.00K derived: sum of 2 quarters · filed 2025-05-08 | $133.00K derived: sum of 3 quarters · filed 2025-05-08 | $191.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $99.00K derived: sum of 2 quarters · filed 2025-03-27 | $157.00K derived: sum of 3 quarters · filed 2025-03-27 | $224.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $112.00K derived: sum of 2 quarters · filed 2024-10-31 | $179.00K 10-Q · filed 2024-10-31 | $247.00K derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | $58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $125.00K 10-Q · filed 2024-08-01 | $193.00K derived: sum of 3 quarters · filed 2024-08-01 | $251.00K derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $67.00K 10-Q · filed 2024-05-09 | $135.00K derived: sum of 2 quarters · filed 2024-05-09 | $193.00K derived: sum of 3 quarters · filed 2024-05-09 | $250.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $126.00K derived: sum of 2 quarters · filed 2024-03-28 | $183.00K derived: sum of 3 quarters · filed 2024-03-28 | $239.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $115.00K derived: sum of 2 quarters · filed 2023-11-01 | $171.00K 10-Q · filed 2023-11-01 | $228.00K derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $113.00K 10-Q · filed 2023-08-07 | $170.00K derived: sum of 3 quarters · filed 2023-08-07 | $223.00K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $56.00K 10-Q · filed 2023-05-03 | $113.00K derived: sum of 2 quarters · filed 2023-05-03 | $166.00K derived: sum of 3 quarters · filed 2023-05-03 | |
| 2021-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $110.00K derived: sum of 2 quarters · filed 2023-03-02 | $126.00K 10-K · filed 2023-03-02 | |
| 2021-09-30 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $69.00K 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | $16.00K 10-Q · filed 2022-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |